CFTR and cystic fibrosis: Prior to the introduction of highly effective CF modulator therapy, the CF Foundation patient registry report showed that at any given year, approximately 40% of patients had one or more exacerbations a year requiring hospitalization and/or intravenous antibiotics and approximately 10% of this group had 3 or more exacerbations a year.